Baird analyst Peter Arment downgrades Maxar Technologies (NYSE:MAXR) from Outperform to Neutral and raises the price target from $45 to $53.
Goldman Sachs Maintains Neutral on PerkinElmer, Lowers Price Target to $175
Goldman Sachs analyst Matthew Sykes maintains PerkinElmer (NYSE:PKI) with a Neutral and lowers the price target from $200 to $175.